2.340USD-0.85%Mkt Cap: 16.28M USDP/E: —Last update: 2026-06-01
Vyome Holdings, Inc., a clinical-stage specialty pharmaceutical company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States. It operates through Pharmaceutical and Biotechn…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap16.28M USD
Enterprise Value8.95M USD
Revenue (TTM)152.72K USD
Gross Profit218.77K USD
Net Income (TTM)-10.26M USD
Revenue/Share0.0400 USD
Last Price2.340 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees9
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.44
EV/Revenue58.59
P/S107.54
P/B2.43
EPS (TTM)-1.56
EPS (Forward)—
52W Range
1.7502% of range33.16
52W High33.16 USD
52W Low1.750 USD
Profitability
Gross Margin68.43%
Oper. Margin-3576.78%
EBITDA Margin0.00%
Profit Margin-3209.75%
ROE-420.22%
ROA-157.95%
Growth
Revenue Growth-84.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.75M USD
CapEx (TTM)—
FCF Margin2695.61%
FCF Yield25.28%
Net Debt-8.77M USD
Net Debt/EBITDA2.39
Balance Sheet
Debt/Equity0.01
Current Ratio4.27
Quick Ratio4.17
Book Value/Sh0.9610 USD
Cash/Share1.253 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateAug 15, 2025
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)11.50 USD
Target Range8.000 USD – 15.00 USD
# Analysts2
Ownership
Shares Out.7.02M
Float3.25M
Insiders52.89%
Institutions1.52%
Short Interest
Short Ratio3.4d
Short % Float2.73%
Short % Out.1.75%
Shares Short123.13K
Short (prev mo.)143.90K
Technical
SMA 502.154 (+8.7%)
SMA 2004.329 (-45.9%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)32.91K
Avg Vol (10d)27.91K
Technical Indicators
RSI (14)64.3
MACD0.0344
MACD Signal-0.0164
MACD Hist.+0.0508
BB Upper2.401 USD
BB Middle2.095 USD
BB Lower1.788 USD
BB Width29.26%
ATR (14)0.1521 USD
Vol Ratio (20d)0.45x